Evidence map›Paper›PMID 37760751›Full record

ArticleAntibiotics (Basel, Switzerland)2023

A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris.

Bela Shah, Deval Mistry, Nelry Gonsalves, Presha Vasani, Dhiraj Dhoot, Hanmant Barkate

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Bela ShahDepartment of Dermatology, B J Medical College, Civil Hospital, Ahmedabad 380016, Gujarat, India.
Deval MistryConsultant Dermatologist, Mistry Skin Clinic, Ahmedabad 301302, Gujarat, India.
Nelry GonsalvesDepartment of Dermatology, B J Medical College, Civil Hospital, Ahmedabad 380016, Gujarat, India.
Presha VasaniDepartment of Dermatology, B J Medical College, Civil Hospital, Ahmedabad 380016, Gujarat, India.
Dhiraj DhootDepartment of Global Medical Affairs, Glenmark Pharmaceuticals Ltd., Mumbai 400099, Maharashtra, India.ORCID 0000-0002-2045-9324
Hanmant BarkateDepartment of Global Medical Affairs, Glenmark Pharmaceuticals Ltd., Mumbai 400099, Maharashtra, India.
B.J. Medical College · INGlenmark Pharmaceuticals (India) · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acne vulgaris is characterized by inflammatory and non-inflammatory skin lesions with a high prevalence among adolescents in India. Not enough studies are reported on the use of topical antibiotics for the management of acne in the Indian population. The proposed study aims to compare the efficacy and safety of topical minocycline gel 4% with topical clindamycin gel 1% in the Indian population. A randomized, open-label, double-arm study was planned at two centers in India. One hundred patients were enrolled and randomized equally to two treatment arms. The drugs were applied once daily, preferably at the same time each day. The number of inflammatory and non-inflammatory lesions, as well as the investigator's global assessment (IGA), were obtained at the baseline and on weeks 3, 6, 9, and 12. The change in these parameters from baseline to week 12 was compared between the two treatment arms. A tolerability assessment was also performed on selected parameters. The age of patients ranged between 14 and 31 years, with female preponderance in each arm. On week 12, the percent change in inflammatory and non-inflammatory lesions in the minocycline 4% arm was significantly higher than in the clindamycin 1% arm (

Indexed as

acne vulgarisclindamycinefficacyinflammatoryinvestigator’s global assessment scoreminocyclinenon-inflammatory lesionssafety

Identifiers

PMID37760751
PMCPMC10526007
OpenAlexW4386848365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.